These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 15123578)

  • 1. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy.
    Matsui Y; Jia N; Okamoto H; Kon S; Onozuka H; Akino M; Liu L; Morimoto J; Rittling SR; Denhardt D; Kitabatake A; Uede T
    Hypertension; 2004 Jun; 43(6):1195-201. PubMed ID: 15123578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition and genetic deficiency of plasminogen activator inhibitor-1 attenuates angiotensin II/salt-induced aortic remodeling.
    Weisberg AD; Albornoz F; Griffin JP; Crandall DL; Elokdah H; Fogo AB; Vaughan DE; Brown NJ
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):365-71. PubMed ID: 15576638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis signal-regulating kinase 1 plays a pivotal role in angiotensin II-induced cardiac hypertrophy and remodeling.
    Izumiya Y; Kim S; Izumi Y; Yoshida K; Yoshiyama M; Matsuzawa A; Ichijo H; Iwao H
    Circ Res; 2003 Oct; 93(9):874-83. PubMed ID: 14551246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart.
    Collins AR; Schnee J; Wang W; Kim S; Fishbein MC; Bruemmer D; Law RE; Nicholas S; Ross RS; Hsueh WA
    J Am Coll Cardiol; 2004 May; 43(9):1698-705. PubMed ID: 15120833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective effects of granulocyte colony-stimulating factor in angiotensin II-induced cardiac remodelling.
    Jia N; Dong P; Huang Q; Jin W; Zhang J; Dai Q; Liu S
    Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):262-6. PubMed ID: 18785976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy.
    Rothermund L; Kreutz R; Kossmehl P; Fredersdorf S; Shakibaei M; Schulze-Tanzil G; Paul M; Grimm D
    Am J Hypertens; 2002 Jul; 15(7 Pt 1):644-52. PubMed ID: 12118914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
    Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
    Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential role of TIMP2 and TIMP3 in cardiac hypertrophy, fibrosis, and diastolic dysfunction.
    Fan D; Takawale A; Basu R; Patel V; Lee J; Kandalam V; Wang X; Oudit GY; Kassiri Z
    Cardiovasc Res; 2014 Jul; 103(2):268-80. PubMed ID: 24692173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice.
    Xie Z; Singh M; Singh K
    Hypertension; 2004 Dec; 44(6):826-31. PubMed ID: 15534078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
    Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
    Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profibrotic effects of angiotensin II in the heart: a matter of mediators.
    Díez J
    Hypertension; 2004 Jun; 43(6):1164-5. PubMed ID: 15117918
    [No Abstract]   [Full Text] [Related]  

  • 12. Apocynin attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction in mice.
    Li YQ; Li XB; Guo SJ; Chu SL; Gao PJ; Zhu DL; Niu WQ; Jia N
    Acta Pharmacol Sin; 2013 Mar; 34(3):352-9. PubMed ID: 23334241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cell-type-specific responses to angiotensin II explain cardiac remodeling differences in C57BL/6 mouse substrains.
    Cardin S; Scott-Boyer MP; Praktiknjo S; Jeidane S; Picard S; Reudelhuber TL; Deschepper CF
    Hypertension; 2014 Nov; 64(5):1040-6. PubMed ID: 25069667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart.
    Mercure C; Yogi A; Callera GE; Aranha AB; Bader M; Ferreira AJ; Santos RA; Walther T; Touyz RM; Reudelhuber TL
    Circ Res; 2008 Nov; 103(11):1319-26. PubMed ID: 18845809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanylyl cyclase-A inhibits angiotensin II type 1A receptor-mediated cardiac remodeling, an endogenous protective mechanism in the heart.
    Li Y; Kishimoto I; Saito Y; Harada M; Kuwahara K; Izumi T; Takahashi N; Kawakami R; Tanimoto K; Nakagawa Y; Nakanishi M; Adachi Y; Garbers DL; Fukamizu A; Nakao K
    Circulation; 2002 Sep; 106(13):1722-8. PubMed ID: 12270869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
    Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
    Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
    Yamazaki T; Yamashita N; Izumi Y; Nakamura Y; Shiota M; Hanatani A; Shimada K; Muro T; Iwao H; Yoshiyama M
    Hypertens Res; 2012 Jan; 35(1):34-40. PubMed ID: 21866107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney.
    Irita J; Okura T; Jotoku M; Nagao T; Enomoto D; Kurata M; Desilva VR; Miyoshi K; Matsui Y; Uede T; Denhardt DT; Rittiling SR; Higaki J
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F833-44. PubMed ID: 21734100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eplerenone prevents adverse cardiac remodelling induced by pressure overload in atrial natriuretic peptide-null mice.
    Franco V; Chen YF; Feng JA; Li P; Wang D; Hasan E; Oparil S; Perry GJ
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):773-9. PubMed ID: 16922805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.